A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
about
Paclitaxel targets VEGF-mediated angiogenesis in ovarian cancer treatmentExamination of the Fractalkine and Fractalkine Receptor Expression in Fallopian Adenocarcinoma Reveals Differences When Compared to Ovarian Carcinoma.Consolidation hyperthermic intraperitoneal chemotherapy for the treatment of advanced stage ovarian carcinoma: a 3 year experience.
P2860
A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peritoneal carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A phase II study of modified d ...... tube, or peritoneal carcinoma.
@ast
A phase II study of modified d ...... tube, or peritoneal carcinoma.
@en
type
label
A phase II study of modified d ...... tube, or peritoneal carcinoma.
@ast
A phase II study of modified d ...... tube, or peritoneal carcinoma.
@en
prefLabel
A phase II study of modified d ...... tube, or peritoneal carcinoma.
@ast
A phase II study of modified d ...... tube, or peritoneal carcinoma.
@en
P2093
P2860
P1476
A phase II study of modified d ...... tube, or peritoneal carcinoma.
@en
P2093
Alberto A Mendivil
Bram H Goldstein
John P Micha
John V Brown
Katrina L Lopez
Lisa N Abaid
Mark A Rettenmaier
P2860
P2888
P304
P356
10.1007/S00280-013-2173-2
P577
2013-05-10T00:00:00Z
P6179
1030064962